Medronic Acid

Medronic Acid

SCHEMBL2823010

NCCN.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Medronic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A known ✓ Q14432 2/20 0.39
PDE4D known ✓ Q08499 1/20 0.39
KDM4E B2RXH2 1/20 0.71
MMP2 P08253 1/20 0.71
THRB P10828 1/20 0.71
MAPK1 P28482 1/20 0.71
HSD17B10 Q99714 1/20 0.71
OTC P00480 1/20 0.58
ALDH1A1 P00352 1/20 0.56
LMNA P02545 3/20 0.50
BLM P54132 2/20 0.50
CYP3A4 P08684 1/20 0.50
NFKB1 P19838 1/20 0.50
PMP22 Q01453 1/20 0.50
ANPEP P15144 2/20 0.43
ERAP2 Q6P179 1/20 0.43
GABBR2 O75899 4/20 0.42
GABBR1 Q9UBS5 4/20 0.42
FDPS P14324 2/20 0.39
ADRB3 P13945 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Medronic Acid SCHEMBL241941 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL1485658 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL12492957 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL19350137 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL78977 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL7743864 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL2353950 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL9550946 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL1707898 1.00 KDM4E (0.71) KDM4EMMP2THRBMAPK1HSD17B10
Medronic Acid SCHEMBL3863755 0.97 KDM4E (0.67) KDM4EMMP2THRBMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11628127-B2 Composition for lightening or dyeing keratin fibers with a low amount of oxidizing agent WELLA OPERATIONS US, LLC (US) 2023-04-18 US claimed
WO-2012154498-A2 REMOVAL OF METAL IMPURITIES FROM SILICON SURFACES FOR SOLAR CELL AND SEMICONDUCTOR APPLICATIONS ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2012-11-15 WO claimed
EP-0819164-B1 DETERGENT COMPOSITION COMPRISING SOURCE OF HYDROGEN PEROXIDE AND PROTEASE ENZYME PROCTER & GAMBLE (US) 2005-07-27 EP claimed
WO-2024126047-A1 BLEACH POWDER AND METHOD FOR BLEACHING HAIR WELLA GERMANY GMBH (DE) 2024-06-20 WO disclosed
EP-4385485-A1 BLEACH POWDER AND METHOD FOR BLEACHING HAIR Wella Germany GmbH (DE) 2024-06-19 EP disclosed
US-20230398042-A1 COSMETIC COMPOSITIONS AND USES THEREOF JPMORGAN CHASE BANK, N.A. 2023-12-14 US disclosed
US-20230381070-A1 COSMETIC COMPOSITIONS AND USES THEREOF COTY INC. 2023-11-30 US disclosed
EP-3773923-B1 HAIR TREATMENT COMPOSITIONS, SYSTEMS, DEVICES AND METHODS WELLA INT OPERATIONS SWITZERLAND SARL (CH) 2023-10-04 EP disclosed
WO-2023152322-A1 HAIR COLORING USING OXIDATIVE DYE PRECURSORS COMPRISING PYRAZOLE PRIMARIES AND COUPLERS, IN COMBINATION WITH SOLUBILIZED VAT DYES, FOR IMPROVING COLOR WASH FASTNESS WELLA GERMANY GMBH (DE) 2023-08-17 WO disclosed
EP-4225256-A1 COSMETIC COMPOSITIONS AND USES THEREOF Coty Inc. (US) 2023-08-16 EP disclosed
EP-4225264-A1 COSMETIC COMPOSITIONS AND USES THEREOF Coty Inc. (US) 2023-08-16 EP disclosed
EP-1847249-A1 HAIRDYE COMPOSITION Kao Corporation (JP) 2007-10-24 EP disclosed
US-7083655-B2 Hair dye composition KAO CORPORATION (JP) 2006-08-01 US disclosed
US-7056355-B2 Hair dye composition and dyeing method KAO CORPORATION (JP) 2006-06-06 US disclosed
US-20050015896-A1 Hair dye composition and dyeing method KAO CORPORATION (JP) 2005-01-27 US disclosed
US-20050003988-A1 Enzyme bleach lipophilic fluid cleaning compositions THE PROCTER & GAMBLE COMPANY 2005-01-06 US disclosed
EP-1398022-A1 Hair dye composition comprising an azo dye containing a dissociative proton, method and use Kao Corporation (JP) 2004-03-17 EP disclosed
US-20040019982-A1 Hair dye composition KAO CORPORATION (JP) 2004-02-05 US disclosed
EP-1369105-A1 Hair dye composition Kao Corporation (JP) 2003-12-10 EP disclosed
US-3959361-A Process of producing amino methylene phosphonic acids JOH. A. BENCKISER GMBH (DT) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019982-A1 Hair dye composition CYBA, SDHB, S100B PDE3A 3500/4885PDE4D 4161/4885KDM4E 760/4885
US-20050015896-A1 Hair dye composition and dyeing method SULT1A1, CYP21A2, SULT2A1 PDE3A 2493/4885PDE4D 2507/4885KDM4E 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.